TBnet

🔰 NTM-NET call for participation in new study: 📣📣📣Calling all physicians managing patients with Non-tuberculous mycobacterial pulmonary disease (NTM-PD) We would be very grateful for 15 minutes of your time to complete this online NTM Network survey to understand the variation in clinical practice across Europe. We hope this information will inform how service providers including clinicians can be supported to manage patients with NTM-PD in the future. Access the survey here: 👉 Follow URL: https://lnkd.in/ebA7A_Vc 👉 Scan QR Code

The European Advanced Course on Clinical Tuberculosis planned for September 2024 is canceled.

📣📣📣 Registration for the TBnet Annual meeting! 🤩 The TBnet Annual Meeting will be held on September 6th in beautiful Vienna, Austria, and registration for the meeting is open on our website until August 4th (online participation also available 👏)! 📣 Check out the meeting details and register for the meeting: https://lnkd.in/ewBwcEXC

The next issue of our monthly TBnet News is now available on the website! In June's edition you can read about: ✅ TBnet & UNITE4TB webinars today ✅ TBnet photo competition - vote now! ✅ Campaigns in Global Health ✅ Save the date! TBnet Annual meeting in Vienna (September 6) ✅ European Advanced Course on Clinical Tuberculosis

Dear colleagues, We would like to remind you that voting for the TBnet Photo Competition is still open, but not for long! Please login to our website using your membership details at https://lnkd.in/dKx86CBf and cast your vote for your favourite picture. The deadline for voting is 28 June, 17:00 CEST

Exciting discussion on access to #tuberculosis #drugs this week! Don't miss the joint TBnet/MSF webinar this week. Thursday 27 June, 17:00 CEST Overcoming the challenges of access to TB medicines in Europe: no more time to waste More details and free registration on our website. https://lnkd.in/dZU3QMvM

Not directly connected to tuberculosis but still a very important report from the WHO analysing the commercial determinants of #noncommunicable diseases in the WHO European Region. Nearly 7500 deaths per day in the Region are attributed to commercial determinants, such as tobacco, alcohol, processed food, fossil fuels and occupational practices. These commercial products and practices contribute to 25% of all deaths in the Region. https://lnkd.in/e5Tsn4cp

✒️ "#GlobalHealthEDCTP3 is the main programme of cooperation with sub-Saharan African countries that focuses on R&I for #health. It is a key activity of the AU-EU Innovation Agenda which, as part of the Global Gateway, supports technological transfer and #innovation". ➡️ Read the latest ECDPM 🔎 🌍 paper, "A partnership in progress: #Africa and the #EU strive for global health and equitable access", commissioned by the Belgian Presidency of the Council of the European Union 2024, that takes stock of the AU-EU health partnership, analyses its current direction and outlines new actions to advance the partnership for #globalhealth. Take a look at the #Research and Innovation section and see how Global Health EDCTP3 has been driving R&I for health in African countries. 🔗 https://lnkd.in/dKBMUAEc -------- Africa CDC EU Science, Research and Innovation European & Developing Countries Clinical Trials Partnership Irene Norstedt Glaudina Loots EURAXESS Africa South African Medical Research Council Global AMR R&D Hub TBnet Science|Business The Lancet West African Network for Tuberculosis, AIDS and Malaria African Union

Our latest UNITE4TB Newsletter is out, packed with updates and insights on our ongoing efforts to accelerate the development of new treatment regimens for tuberculosis (TB). Here’s a sneak peek at what’s inside: 🔹 2024 Annual Consortium Meeting & Joint Symposium with ERA4TB: Highlights and key takeaways from this event, emphasizing the importance of collaborative efforts in TB research. 🔹 World TB Day Activities: A look back at our activities to mark this year's awareness day. 🔹 Upcoming UNITE4TB webinar: Join us on 27 June for an in-depth discussion on approaches to market-shaping and access to TB medicines. 🔹 Publications: New publications from the UNITE4TB Consortium 🔗👉 https://lnkd.in/esEEiJjc Subscribe to our newsletter for the latest news and updates (see link in comments) #UNITE4TB #EndTB #Newsletter #SubscribeNow #GlobalHealth #PublicPrivatePartnership funded by the Innovative Medicines Initiative 2 (Innovative Health Initiative (IHI)). Proud partner of the AMR Accelerator.

Don't miss the UNITE4TB webinar on market-shaping and access to #tuberculosis medicines!